baber/WOPTO huggingface dataset:
Patent NZ-563502-A (NZ)
Title: Apparatus for preventing pallet movement by blocking the access of a forklift tine to one of the pallet tunnels
Inventor: BEARZOT GEORGE
IPC: B65D19/38
Filed: 2006-05-12
Abstract: A pallet arrestor (12) is disclosed for preventing the movement of a pallet (10), having one or more pallet tunnels (16, 18) for receiving the tines of a forklift. The pallet arrestor (12) includes a moulded plastic plug (12) which has a first portion (30) which is configured to slot into a pallet tunnel (16, 18) and a front portion (32) whose height prevents its entry into the tunnel. The pallet arrestor (12) prevents ingress of a forklift tine into that pallet tunnel, and hence inhibits movement of the pallet, without having to move the pallet to a caged area, or the like. The plug (12) may include a rotatable latch (34) which in one (retracted) position allows the pallet arrester (12) to be inserted and removed from the pallet tunnel and which in a second (locked) position prevents or inhibits the removal of the pallet arrestor (12) from the pallet tunnel. Typically, the latch (34) is rotatably mounted on the distal end of the pallet arrestor and in the locked position is disposed between two of the planks forming the upper surface of the pallet. For security reasons, operation of the latch (34) may be via a key operated lock (36) located on the front of the pallet arrestor. However, the plug may also be configured without a rotatable latch and rely solely on friction to keep it located within the pallet tunnel.
Patent NZ-563942-A (NZ)
Title: Disc implant device
Inventor: JOHANSSON ERIK
IPC: A61F2/44
Filed: 2006-05-31
Abstract: A device in a disc implant (2) for positioning between two vertebrae (3,3') in a spinal column, the disc implant including two contacting elements (14,14') for contacting each one vertebra and an intermediate articulation device (15) includes at least one sealing element (13,13') for attachment to a peripheral part of one of the contacting elements for sealing between that element and an adjacent vertebra. Also disclosed is a disc implant.
Patent NZ-567210-A (NZ)
Title: DNA modular cloning vector plasmids and methods for their use
Inventor: REED THOMAS
IPC: C12N7/00
Filed: 2006-09-22
Abstract: Disclosed is a domain module docking vector consisting of a DNA cloning vector, comprising a multiple cloning (MC) module for sub-cloning a genetic material of interest into the MC module, the MC module comprising: a) a first gene pivot (GP) comprising at least two non-variable restriction sites of greater than six nucleotides; b) a nucleic acid sequence comprising a multiple cloning site (MCS) comprising a plurality of restriction sites selected from common restriction sites that are unique within the domain module docking vector, to provide cloning sites for the cloning of the genetic material of interest into the MC module; and c) a second gene pivot comprising at least two non-variable restriction sites of greater than six nucleotides, wherein the first gene pivot and the second gene pivot independently consists of four non-variable rare restriction sites.
Patent NZ-568512-A (NZ)
Title: Non-peroxide preparation for whitening natural and manufactured teeth
Inventor: BERGERON CHANTAL
IPC: A61K8/64
Filed: 2006-08-16
Abstract: Disclosed is a peroxide-free method for whitening natural or manufactured teeth, the method comprising: (a) providing an actinidin-containing preparation; (b) formulating the actinidin-containing preparation of step (a) for application to natural or manufactured teeth; and (c) contacting the formulation of step (b) with natural or manufactured teeth in an amount and for a period of time sufficient to effect whitening of the natural or manufactured teeth; wherein the actinidin-containing preparation is formulated in: a whitening strip, a dentifrice, a mouthrinse, a mouthwash, chewing gum, a preparation for soaking manufactured teeth or a whitening tray.
Patent NZ-576226-A (NZ)
Title: Patient incline device with a centerline spinal support
Inventor: WEEDLING ROBERT E
IPC: A61G7/07
Filed: 2007-10-24
Abstract: A patient incline device 10 includes an incline ramp 12 and a centreline spinal support 14 located on a base member 12. The incline ramp 12 supports the upper torso and head of a patient such that the upper torso and head are elevated with respect to the base member 12. The centreline support 14 is located adjacent the inline ramp 12 for contact with a central portion of the patient's back located adjacent the spine to elevate the central back portion. The width of the spinal support 14 is less than that of the incline ramp 12 to define lateral spaces along opposite sides of the centreline support 14 to receive the arms and side portions of the patient for lateral extension of the chest wall.
Patent NZ-576414-A (NZ)
Title: Bolus in form of plural dosage media connected by flexible material
Inventor: LEECH WAYNE FREDERICK
IPC: A61D7/00
Filed: 2009-04-21
Abstract: A bolus is formed from plural dosage media bound together with a length of flexible material having a higher disintegration rate than the media.
Patent NZ-577804-A (NZ)
Title: Genetic susceptibility variants of type 2 diabetes mellitus
Inventor: STEINTHORSDOTTIR VALGERDUR
IPC: C12Q1/68
Filed: 2007-11-30
Abstract: Provided is a method of determining a susceptibility to Type 2 diabetes in a human individual, comprising determining the presence or absence of at least one allele of at least one polymorphic marker in a nucleic acid sample obtained from the individual, or in a genotype dataset derived from the individual, wherein the at least one polymorphic marker is selected from rs7756992, and markers in linkage disequilibrium therewith, and wherein determination of the presence or absence of the at least one allele is indicative of a susceptibility to Type 2 diabetes.
Patent NZ-580686-A (NZ)
Title: Modified interferon beta polypeptides and their uses
Inventor: KRAYNOV VADIM
IPC: A61K38/21
Filed: 2008-04-30
Abstract: Provided is modified interferon (IFN)-beta polypeptide comprising a specified amino acid sequence or its variant modified by the presence of one or more non-naturally encoded amino acids therein, each non-naturally encoded amino acid being present at a residue position selected from 36 and 111 or corresponding residue position(s), wherein the non-naturally encoded amino acid is p-acetyl-phenylalanine (pAF), and wherein said IFN beta polypeptide is linked to a water-soluble polymer comprising a poly(ethylene glycol) moiety and having a molecular weight of about 30 kDa or about 40 kDa. Further provided are corresponding DNA sequences and use of the compositions for manufacturing medicaments for cancer and viral infections.
Patent NZ-580751-A (NZ)
Title: Continuous counter-current organosolv processing of lignocellulosic feedstocks
Inventor: HALLBERG CHRISTER
IPC: C12M1/00
Filed: 2008-04-25
Abstract: Disclosed herein are fractionation of lignocellulosic feedstocks into component parts, in particular, processes, systems and equipment configurations for recyclable organosolv fractionation of lignocellulosic material for continuous controllable and manipulable production and further processing of lignins, monosaccharaides, oligosaccharides, polysaccharides and other products derived therefrom. Particularly described is a modular process for organosolv fractionation of a lignocellulosic feedstock into a solids fraction and a liquids fraction and recovering therefrom at least an alcohol and one class of lignin derivatives, the modular process comprising: a. a first processing module provided with a first series of steps for receiving, physically screening, and physico-chemically digesting a lignocellulosic feedstock with an organic solvent separately provided thereto thereby extracting component parts therefrom, and separating said component parts into a cellulosic solids fraction and a first liquid fraction; b. a second processing module provided with a second series of steps for separating ethanol and a plurality of a first class of lignin derivatives from said cellulosic solids fraction; c. a third processing module provided with third series of steps comprising at least a first step for separating the first liquid fraction into a second solids fraction comprising a plurality of a second class of lignin derivatives and a first filtrate, a second step for separating the first filtrate into a third solids fraction comprising a plurality of a third class of lignin derivatives and a second filtrate, and a third step for separating furfurals from said filtrate, a fourth step for recovering a portion of the organic solvent from the filtrate by distillation thereby producing a first stillage; and d. a fourth processing module provided with a fourth series of steps for separating the first stillage into one or more of an acetic acid-containing liquid fraction, a plurality of a fourth class of lignin derivatives, a monosaccharide sugar syrup, and a solid waste material.
Patent NZ-583663-A (NZ)
Title: Fungicidal 2-alkylthio-2-quinolinyloxy-acetamide derivatives
Inventor: BEAUDEGNIES RENAUD
IPC: A01N43/42
Filed: 2008-09-03
Abstract: Disclosed are 2-alkylthio-2-quinolinyloxy-acetamide derivatives of formula (I) wherein Ar is a group of formula (A) and the remaining substituents are as defined in the specification. Also disclosed are processes for preparing them, to compositions containing them and to methods of using them to control phytopathogenic fungi.
Patent NZ-584159-A (NZ)
Title: 6,11-bridged biaryl macrolides
Inventor: KIM IN JONG
IPC: C07H17/00
Filed: 2008-09-17
Abstract: Disclosed are macrolide compounds of formula (I) containing a biaryl moiety on a 6, 11-bridged macrolide system, wherein the substituents are as described within the specification. Further disclosed is a pharmaceutical composition comprising a compound of formula (I), and the use of said compound in the manufacture of a medicament for treating a bacterial infection, cystic fibrosis or an inflammatory disorder in a subject in need thereof.
Patent NZ-584463-A (NZ)
Title: Honey composition for treating wounds
Inventor: THOMPSON FATMA BILGE
IPC: A61K35/64
Filed: 2011-04-07
Abstract: Disclosed is a composition for treating a patient wherein the composition comprises: (a) at least 50%wt honey or a honey analogue;(b) 2-15%wt of a natural based short chain fatty alcohol with non-ionic surfactant properties selected from fatty alcohols with a tail comprising 6 to 10 carbon atoms; (c) 1 to 50%wt of at least one natural based topical carrier or vehicle with a set point of 45 Deg C or less selected from the group consisting of: a fatty ester, synthetic wax, beeswax, vegetal wax, mineral wax, a spermaceti wax constituent, carnauba wax and jojoba liquid wax,wherein the composition has been subjected to a sterilisation effective dosage of radiation and is storage stable for a time period of at least 24 hours at 40 Deg C. Also disclosed is an irradiated gelatinous composition consisting of: (a) 70-90%wt honey; (b) 2-15%wt myristyl myristate; and (c) 2-10%wt caprylyl capryl glucoside.
Patent NZ-595473-A (NZ)
Title: Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
Inventor: SCHUELE MARTIN
IPC: A61K31/535
Filed: 2010-04-30
Abstract: 595473 Disclosed is a monohydrate of an oxodihydropyridine ethyl phenyl pyridine substituted [1,3]oxazinan-2-one compound of formula (Ip3). An example of compounds of formula (Ip3) is (S)-6-(2-hydroxy-2 -methylpropyl)-3-((S)-1-(4-(1-methyl-2-oxo-1,2 -dihydropyridin-4-yl)phenyl)ethyl)-6-phenyl-1,3-oxazinan-2-one. Also disclosed are pharmaceutical compositions of the novel compounds and methods for their use in the reduction or control of the production of Cortisol in a cell or the inhibition of the conversion of cortisone to Cortisol in a cell.
Patent NZ-597514-A (NZ)
Title: 5- (3, 4-dichloro-phenyl) -n- (2-hydroxy-cyclohexyl) -6- (2,2, 2-trifluoro-ethoxy) -nico tinamide and salts thereof as hdl cholesterol raising agents
Inventor: ROEVER STEPHAN
IPC: A61K31/465
Filed: 2010-09-08
Abstract: 597514 Disclosed herein is a compound of formula I, specifically 5(-3,4-dichloro-phenyl)-N-2-hydroxy-cycloexyl)-6-(2,2,2-trifluoro-ethoxy)-nicotinamide, preferably (1S, 2R)-I or (1R, 2R)-I. Additionally disclosed is a process for the manufacture thereof comprising coupling a halide intermediate with a boronic acid or boronic acid ester, in the presence of a palladium catalyst under basic conditions. Additionally disclosed is the use thereof in the treatment of diseases which can be treated with HDL-cholesterol raising agents.
Patent NZ-600516-A (NZ)
Title: Nitrooxy alkanoic acids and derivatives thereof in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
Inventor: KINDERMANN MAIK
IPC: A23K1/18
Filed: 2010-12-10
Abstract: 600516 Disclosed is a method for reducing the production of methane emanating from the digestive activities of a ruminant and or for improving ruminant animal performance by using, as active compound at least one nitrooxy alkanoic acid and/or derivative defined by formula (I), which is administrated to the animal together with the feed. Also disclosed is the use of these compounds in feed and feed additives such as premix, concentrates and total mixed ration (TMR) or in the form of a bolus
Patent NZ-603198-A (NZ)
Title: Novel hydroxamic acid derivative
Inventor: TAKASHIMA HAJIME
IPC: C07D498/08
Filed: 2011-04-20
Abstract: Disclosed herein are hydroxamic acid derivatives of formula [1], wherein the substituents are as defined within the specification, processes for preparing them, composition comprising said compounds and uses thereof. Said compounds are useful as inhibitors of uridyldiphospho(UDP)-3-O-acyl-N-acetylglucosamine deacetylase (LpxC) and as antimicrobial. Particularly preferred compounds include: 2-[{ [4'-(fluoromethyl)biphenyl-4-yl]carbonyl} (methyl)amino]-N-hydroxy-N'-methylpropanediamide, 2-{ [4-(2,3-dihydro-1-benzofuran-6-yl)benzoyl](methyl)amino} -N-hydroxy-N'-methylpropanediamide; N-(cyclopropylmethyl)-N'-hydroxy-2-({ [4'-(2-hydroxyethoxy)biphenyl-4-yl]carbonyI} amino)propanediamide, N-hydroxy-2-({ [4'-(2-hydroxyethoxy)biphenyl-4-yl]carbonyl} amino)-N'-[2-(propan -2-yloxy)ethyl]propanediamide, N-hydroxy-2-({ [4'-(2-hydroxyethoxy)biphenyl-4-yl]carbonyl} amino)-N'-(1,3-thiazol-5-ylmethyl)propanediamide, N-(furan-2-ylmethyl)-N'-hydroxy-2-({ [4'-(2-hydroxyethoxy)biphenyl-4-yl]carbonyI} amino)propanediamide.
Patent NZ-609666-A (NZ)
Title: Methods and compositions for diagnosis and prognosis of renal injury and renal failure
Inventor: NAKAMURA KEVIN
IPC: C12Q1/42
Filed: 2010-02-05
Abstract: Disclosed is an ex vivo method for evaluating renal status in a subject, comprising: performing one or more assays configured to detect Soluble endothelial protein C receptor in a body fluid sample obtained previously from the subject to provide one or more assay results, wherein an assay configured to detect Soluble endothelial protein C receptor comprises contacting the body fluid sample with one or more antibodies or antibody fragments that bind to Soluble endothelial protein C receptor or part thereof, to thereby form a complex, and determining a measured concentration of Soluble endothelial protein C receptor in the body fluid sample based on an amount of the complex formed; and correlating the assay result(s) to one or more of risk stratification, staging, prognosis, classifying and monitoring of the renal status of the subject, wherein said correlating comprises comparing the measured concentration of Soluble endothelial protein C receptor to a threshold concentration of Soluble endothelial protein C receptor, and assigning a likelihood of a future event occurring or determining that an event has occurred when the measured concentration varies from the threshold, or assigning a likelihood of a future event not occurring or determining that an event has not occurred when the measured concentration does not vary from the threshold.
Patent NZ-614216-A (NZ)
Title: Auto-injector
Inventor: EKMAN MATTHEW
IPC: A61M5/20
Filed: 2012-02-16
Abstract: The invention relates to an auto-injector (1) for administering a dose of a liquid medicament (M). The auto-injector has an elongate tubular case (12) with a carrier subassembly comprising a tubular carrier (7) slidably arranged inside the case (12). The carrier (7) is adapted to contain a syringe (3) with a hollow injection needle (4), a drive spring (8) and a plunger (9) for forwarding load of the drive spring (8) to a stopper (6) of the syringe (3). The syringe (3) is lockable for joint axial translation with the carrier (7). The drive spring (8) acts between the carrier (7) and the plunger (9). The plunger (9) in an initial state is locked to the carrier (7) by a ramped engagement to the carrier (7) and by being prevented from rotating out of this ramped engagement depending on a relative longitudinal position of the carrier (7) in the case (12). The plunger (9) is arranged to be released for rotating out of the ramped engagement upon the needle (4) reaching at least nearly a predefined injection depth on translation of the carrier (7) in the proximal direction (P) for advancing the needle (4) beyond a proximal end of the auto-injector (1).
Patent NZ-619475-A (NZ)
Title: Improvements to suppressors and their methods of manufacture
Inventor: BERT JOHN WILSON
IPC: B22F3/00
Filed: 2012-12-21
Abstract: 619475 A method of manufacturing a product, such as a rifle suppressor (30), having a housing (2) with a cavity and at least one component (12-15) within the cavity using selective metal melting is disclosed. The method includes the step determining an angle between an underside of a component to be formed and a surface of a wall inside the housing to be between 10° and 85°. This allows for baffles and other structures to be supported by the un-melted metal powder during manufacture. The manufacture of a muzzle break and a quick release fastening is also disclosed using the same technique is also disclosed.
Patent NZ-624064-A (NZ)
Title: Improvements to delivery devices
Inventor: WAYNE FREDERICK LEECH
IPC: A61M5/19
Filed: 2013-01-18
Abstract: A delivery device (1) for the sequential delivery of at least two substances for example and antibiotic and sealant for treating dairy cow teats is disclosed. The device includes a body (2), a plunger (3) and a partition (5) defining a first chamber (6) in front of the partition and a second chamber (7) behind the partition. The partition (5) includes a conduit (8) for passage of a substance from the second chamber (7) to the first chamber (6). The partition (5) includes a deformable component in the form of a hinged flap (9) that engages with the conduit in a closed position to prevent passage of a substance between chambers. When the hinged flap (9) is opened, for example by pressure in the second chamber (7), the substance in the second chamber (7) can be ejected through the first chamber (6) to an outlet (4).
Patent NZ-631011-A (NZ)
Title: A blister pack
Inventor: GEOFFREY FRANCIS WHEELER
IPC: B65D83/04
Filed: 2014-09-12
Abstract: A blister pack (100) having a base with a plurality of blister sections (128) arranged in a sheet (132), including: a recess, a shoulder a shoulder surrounding the recess, wherein each blister section is defined by demarcation lines between the shoulders, at least one tab section (134) in each shoulder, in which the edge of the shoulder is not directly connected to the shoulders of neighbouring blister sections, wherein the majority of blister sections include at least two tab sections.
Patent NZ-711629-A (NZ)
Title: Density phase separation device
Inventor: BARTFELD BENJAMIN
IPC: G01N1/10
Filed: 2010-05-14
Abstract: A separation assembly (40) for enabling separation of a fluid sample into first and second phases, comprising: a collection container (82) having a first end, a second end, and a sidewall extending therebetween; a closure adapted for sealing engagement with the first end of the collection container; and a device comprising a body having a through-hole (46) defined therethrough, the device having a first sealing perimeter for providing sealing engagement with a first portion of the collection container while allowing a sample to pass through the through-hole into the collection container, and a second sealing perimeter for providing sealing engagement with a second portion of the collection container while maintaining a barrier for separation between the first and second phases, wherein the through-hole is defined along a through-axis and the first sealing perimeter and the second sealing perimeter are at different angles with respect to the through-axis.
Patent NZ-716796-A (NZ)
Title: Ergonomic duty belt assembly
Inventor: GREGORY MAY
IPC: A61F5/03
Filed: 2016-02-09
Abstract: Due to unevenly distributed and weighted equipment carried on the side or the front of duty belt assemblies, wearers often complain of back aches and pain and postural problems. The rigidity of the belt adds to the issue when wearers have to maintain various upright, sitting, squatting and bent over positions. An Described is an ergonomic duty belt assembly comprising: a longitudinally and laterally flexible inner belt having an exterior face provided with a hook and loop fabric; a longitudinally and laterally flexible supporting belt adapted to be affixed over said inner belt having an interior face provided with mating hook and loop fabric; a base material of each of said inner belt, said supporting belt, said hook and loop fabric and said mating hook and loop fabric being woven with a material having elasticity properties, thus providing longitudinal and lateral flexibility of said duty belt assembly; said supporting belt further comprising at least one polymer insert affixed between the base material layer and the hook and loop fabric of the supporting belt, wherein the polymer insert is not stretchable longitudinally although it may be somewhat flexible; and said outer belt being removably mountable to said inner belt, said hook and loop fabric on said inner belt being adapted to be affixed to said mating hook and loop fabric of said supporting belt.
Patent NZ-746440-A (NZ)
Title: Glycinamide derivatives and production methods thereof
Inventor: MASUDA TAKESHI
IPC: C07K16/28
Filed: 2013-10-10
Abstract: Provided is compounds: Glycylglycyl-L-phenylalanyl-N-[(2-{ [(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino} -2-oxoethoxy)methyl]glycineamide, N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycylglycyl-L-phenylalanyl-N-[(2-{ [(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H- benzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino} -2-oxoethoxy)methyl]glycineamide, N-[(2-{ [(1S,9S)-9-Ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino} -2- oxoethoxy)methyl]glycineamide, 9H-Fluoren-9-ylmethyl(2-{ [(2-{ [(1S,9S)-9-ethyl-5-fluoro-9-hydroxy-4-methyl-10,13-dioxo-2,3,9,10,13,15-hexahydro-1H,12H-benzo[de]pyrano[3’,4’:6,7]indolizino[1,2-b]quinolin-1-yl]amino} -2-oxoethoxy)methyl]amino} -2-oxoethyl)carbamate, and [({ N-[(9H-Fluoren-9-ylmethoxy)carbonyl]glycyl} amino)methoxy]acetic acid. Said compounds are useful in the manufacture of antibody-drug conjugates (ADCs) for treating tumours.